In contrast, ICI can block the binding of PD-1 and PD-L1, upregulate the growth and proliferation of T cells, enhance the recognition of tumor cells by T cells, and activate their attack and killing functions, thus realizing their antitumor effect. The gene discussed is CD274; the disease is neoplasm.